EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-Releasing Conductive Hydrogels for Brain–Computer Interface Electrodes: Materials, Biosafety, and Regulatory Considerations

Jiajia Zang, Yaya Cui, Yucheng Gao, Qiong Yan, Yue Wang, Chunqing Zhang, Haibin Wang

Gels · 15.11.2026 · 12 (11) · 1046

DOI: 10.3390/gels12111046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gels, online erschienen am 15.11.2026. Verfasst von Jiajia Zang und 6 weiteren Autor:innen. Die Arbeit nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Key Project for the Development of the Regulatory Science System.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The long-term stability of brain–computer interface (BCI) electrodes depends not only on the quality of neural signal acquisition but also on mechanical mismatch at the electrode–neural tissue interface, chronic inflammation, glial scarring, and progressive signal attenuation. Conductive hydrogels combine high water content, low modulus, and favorable interfacial conformity, allowing them to mitigate several limitations of conventional neural electrodes and making them promising materials for BCI electrode design. However, improvements in flexibility and conductivity alone are insufficient to address implantation-induced foreign-body responses. Drug-releasing conductive hydrogels additionally incorporate anti-inflammatory agents, neurotrophic factors, or immunomodulatory molecules into conductive hydrogel networks. While maintaining electrical signal transmission and interfacial conformity, these systems may also modulate local inflammation, glial activation, and neuronal retraction. Existing reviews have largely focused on the functional material design of hydrogel-based BCI interfaces, with limited attention to the regulatory considerations associated with their clinical translation. This review examines the matrix materials, conductive components, and interfacial functionalization strategies of conductive hydrogels, with particular emphasis on drug-delivery approaches and their potential applications in BCI neural electrodes. From a drug–device combination product perspective, we further discuss product classification and biological safety evaluation requirements within the regulatory frameworks of China, the United States, and the European Union, with the aim of informing material development, clinical translation, and science-based regulation.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Key Project for the Development of the Regulatory Science System

Zitieren

APA

Zang, J., Cui, Y., Gao, Y., Yan, Q., Wang, Y., Zhang, C., & Wang, H. (2026). Drug-Releasing Conductive Hydrogels for Brain–Computer Interface Electrodes: Materials, Biosafety, and Regulatory Considerations. Gels, 12(11), 1046. https://doi.org/10.3390/gels12111046

Vancouver

Zang J, Cui Y, Gao Y, Yan Q, Wang Y, Zhang C, et al. Drug-Releasing Conductive Hydrogels for Brain–Computer Interface Electrodes: Materials, Biosafety, and Regulatory Considerations. Gels. 2026;12(11):1046. doi:10.3390/gels12111046

BibTeX
@article{Zang2026,
  author = {Zang, Jiajia and Cui, Yaya and Gao, Yucheng and Yan, Qiong and Wang, Yue and Zhang, Chunqing and Wang, Haibin},
  title = {Drug-Releasing Conductive Hydrogels for Brain–Computer Interface Electrodes: Materials, Biosafety, and Regulatory Considerations},
  journal = {Gels},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {1046},
  doi = {10.3390/gels12111046}
}
Kostenlos starten →